Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 40 points (0.2%) at 18,080 as of Tuesday, June 2, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,713 issues advancing vs. 1,260 declining with 163 unchanged. The Financial sector currently sits up 0.2% versus the S&P 500, which is up 0.1%. Top gainers within the sector include Banco Santander Brasil SA/Brazil ( BSBR), up 5.5%, Deutsche Bank ( DB), up 4.3%, Credit Suisse Group ( CS), up 3.3%, KB Financial Group ( KB), up 2.4% and ING Groep N.V ( ING), up 2.2%. On the negative front, top decliners within the sector include FirstService ( FSRV), down 35.8%, HDFC Bank ( HDB), down 2.7%, Nomura Holdings ( NMR), down 1.4% and Simon Property Group ( SPG), down 0.8%. TheStreet would like to highlight 3 stocks pushing the sector higher today: 3. MetLife ( MET) is one of the companies pushing the Financial sector higher today. As of noon trading, MetLife is up $0.78 (1.5%) to $53.05 on average volume. Thus far, 2.3 million shares of MetLife exchanged hands as compared to its average daily volume of 6.0 million shares. The stock has ranged in price between $52.16-$53.17 after having opened the day at $52.31 as compared to the previous trading day's close of $52.27. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. MetLife has a market cap of $58.3 billion and is part of the insurance industry. Shares are down 3.4% year-to-date as of the close of trading on Monday. Currently there are 11 analysts who rate MetLife a buy, no analysts rate it a sell, and 3 rate it a hold. TheStreet Ratings rates MetLife as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, attractive valuation levels and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full MetLife Ratings Report now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.